RealMoney

Latest from Helene Meisler

Real Money authors - Helene Meisler

'If It Looks Great, It's Too Late,' So Look Here Instead

Helene Meisler Dec 7, 2021 6:00 AM EST

Good charts can turn bad and bad charts can turn good, and that's a big reason I prefer to focus on the indicators. So, let's dig in.

Markets

Is This the Edge of a Bluff or the Start of a Climb Higher?

James "Rev Shark" DePorre
Dec 7, 2021 6:23 PM EST

Here Are the QQQ Levels Investors Need to Watch Right Now

Timothy Collins

Dec 7, 2021 6:47 PM EST
Investing

Freeport-McMoRan Has Just What the 'Doctor' Ordered

Brad Ginesin
Dec 7, 2021 12:30 PM EST

The copper that goes into an electric vehicle is almost four times as great as a similar legacy internal combustion engine vehicle.
Bitcoin

But Wait, Bitcoin Was Supposed to Be a Decorrelated Asset

Maleeha Bengali
Dec 7, 2021 6:10 PM EST

It is quite ironic that the one asset that was truly meant to be a diversification tool, ended up being just the same as the rest.
ETFs

Meet the New ETF on the Block(chain)

Mark Abssy
Dec 7, 2021 6:12 PM EST

Let's make sense of investing in non-fungible tokens as they meet exchange-traded funds with the recent launch of the Defiance Digital Revolution fund.
Stocks

MongoDB Is Swimming With Some Pretty Big Fish: Here's a Way to Trade It

Stephen Guilfoyle
Dec 7, 2021 11:30 AM EST

Our Updated Strategy as AbbVie Finally Breaks Out to New Highs

Bruce Kamich

Dec 7, 2021 9:40 AM EST

UPGRADES & DOWNGRADES

KMX

CarMax Raised at JPMorgan

Dec 07, 2021

07:26 AM EST

CarMax was raised to Overweight at JPMorgan with a $160 price target.
GRWG

GrowGeneration Rated at Wells Fargo

Dec 07, 2021

07:25 AM EST

GrowGeneration was rated New Equal-Weight at Wells Fargo with a $18 price target.
MRNA

Moderna Rated at Cowen

Dec 07, 2021

07:23 AM EST

Moderna was rated New Market Perform at Cowen with a $250 price target.
ZBH

Zimmer Biomet Rated at Loop Capital

Dec 07, 2021

07:22 AM EST

Zimmer Biomet was rated New Buy at Loop Capital with a $165 price target.
DOCU

DocuSign Cut at Wolfe

Dec 06, 2021

06:27 AM EST

DocuSign was cut to Peerperform at Wolfe with a $140 price target.
See More

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login